Creatine monohydrate increases brain creatine levels and cognition significantly for alzheimer dementia

The claim that creatine monohydrate significantly increases brain creatine levels and cognition in Alzheimer's dementia is supported by some evidence, but it remains nuanced and requires further investigation. Several sources suggest that creatine supplementation may enhance cognitive function, particularly in conditions characterized by brain creatine deficits, which could include Alzheimer's disease. However, the evidence is primarily preliminary and derived from animal studies or small-scale human trials, indicating that while there may be potential benefits, they are not yet conclusively established. Some studies highlight a minor effect on cognitive improvement, suggesting that while creatine could serve as a supplementary treatment, more rigorous and controlled research is necessary to validate these findings and determine the extent of its efficacy in human subjects with Alzheimer's.